Patients undergoing transcatheter atrial septal defect (ASD) closure did not have worsening migraines after completing a course of dual antiplatelet therapy, the CANOA investigators found. Overall, ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A new restaurant could fill a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback